Business Services

Showing 15 posts of 2294 posts found.

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

April 27, 2023 Business Services CHMP, Cosentyx, Dermatology, Novartis

Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

April 26, 2023 Business Services

Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …

Epsilogen announces significant expansion of management team with three new senior hires

April 26, 2023 Business Services

London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …

MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases

April 25, 2023 Business Services

London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …

PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023 Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

April 25, 2023 Business Services

London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …

Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference

April 25, 2023 Business Services

Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …

National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma

April 24, 2023 Business Services

High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

April 24, 2023 Business Services

Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

April 24, 2023 Business Services

WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

April 24, 2023 Business Services

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023 Business Services

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …

Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery

April 19, 2023 Business Services

New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …

Latest content